ADVANCED PROSTATE CANCER
Clinical trials for ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new injection tame prostate cancer by cutting testosterone?
Disease control CompletedThis phase 3 trial is testing an investigational drug called DKF-MA102 (leuprorelin acetate) in men with advanced prostate cancer. The goal is to see if two injections, given 12 weeks apart, can safely lower testosterone levels to a target range, which may help control the cancer…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE3 • Sponsor: Dongkook Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New shot could tame prostate cancer by blocking testosterone
Disease control CompletedThis study tests a new long-acting injection called Debio 4228 for men with advanced prostate cancer. The goal is to lower testosterone levels to control the cancer. About 55 men will receive different doses to find the best one. This is not a cure, but a way to manage the diseas…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New 6-Month shot shows promise for prostate cancer control
Disease control CompletedThis study tested a single injection of triptorelin pamoate that lasts 6 months in 195 Chinese men with advanced or metastatic prostate cancer. The goal was to lower testosterone to castrate levels, which helps slow cancer growth. Results showed the injection effectively reduced …
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Jun 26, 2026 14:39 UTC